Bioluminescent Orthotopic Pancreatic Cancer Mouse Model: A Non-invasive Technique to Monitor Cancer Progression in Mice

Published: April 30, 2023

Abstract

Source: Chai, M. G., et al. Bioluminescent Orthotopic Model of Pancreatic Cancer ProgressionJ. Vis. Exp. (2013).

This video demonstrates an orthotopic model of pancreatic cancer that utilizes Matrigel for localized cell delivery and in vivo bioluminescence imaging for non-invasive monitoring of tumor progression. The orthotopic model is suited to both syngeneic and xenograft models and could be used in pre-clinical trials to investigate the impact of novel anti-cancer therapeutics on the growth of the primary pancreatic tumor and metastasis.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1. Transducing Pancreatic Cancer Cell Lines Transduce pancreatic cancer cells to express luciferase as previously described. Panc-1 and Capan-1 pancreatic cancer cell lines transduced with firefly luciferase are used here. Note: Renilla luciferase or bacterial luciferase may also be used. <p cla…

Declarações

The authors have nothing to disclose.

Materials

Clean Bench coat
Heating pad Set to 37 °C
Ivis Lumina ll Bioluminescent imager Caliper Alternative bioluminescent imaging systems include In vivo F PRO (Carestream) and Photon Imager (Biospace Lab)
Dissecting scissors
Iris forceps (serrated)
Needle holder
27 G 0.3 ml insulin syringe Terumo T35525M2913

Play Video

Citar este artigo
Bioluminescent Orthotopic Pancreatic Cancer Mouse Model: A Non-invasive Technique to Monitor Cancer Progression in Mice. J. Vis. Exp. (Pending Publication), e20324, doi: (2023).

View Video